Publikation
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial
Wissenschaftlicher Artikel/Review - 04.01.2013
Oakman C, Harvey V, Punzalan L, Dell'orto P, Larsimont D, Steinberg I, Gelber R D, Piccart-Gebhart M, Viale G, Gutiérrez J, Thürlimann Beat, Jakesz R, Francis P A, Crown J, Quinaux E, Buyse M, De Azambuja E, Margeli Vila M, Andersson M, Nordenskjöld B, Di Leo A
Oakman, C
1
0
Francis, P A
2
0
Crown, J
1
0
Quinaux, E
1
0
Buyse, M
1
0
De Azambuja, E
4
0
Margeli Vila, M
1
0
Andersson, M
1
0
Nordenskjöld, B
1
0
Jakesz, R
4
0
Thürlimann, Beat
259
14
Gutiérrez, J
1
0
Harvey, V
2
0
Punzalan, L
1
0
Dell'orto, P
3
0
Larsimont, D
1
0
Steinberg, I
1
0
Gelber, R D
40
0
Piccart-Gebhart, M
10
0
Viale, G
12
0